Adient (ADNT) PT Lowered to $27 at Morgan Stanley
Tweet
Share
E-mailGet Alerts ADNT Hot Sheet
Price: $18.62 -2.72%
Rating Summary:
10 Buy, 11 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
10 Buy, 11 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Morgan Stanley analyst Adam Jonas lowered the price target on Adient (NYSE: ADNT) to $27.00 (from $31.00) while maintaining a Underweight rating.
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Lemon Tree Hotels (LEMONTRE:IN) PT Raised to INR180 at Macquarie
- Globe Telecom (GLO:PM) (GTMEY) PT Lowered to PHP1,930 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
